A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis ; volume:8 ; number:1 ; day:18 ; month:12 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.12.2018), 1-13, 12.2018

Creator: Farzaneh Behelgardi, Maryam
Zahri, Saber
Mashayekhi, Farhad
Mansouri, Kamran
Asghari, S. Mohsen

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-018-36394-0

URN: urn:nbn:de:101:1-2019012821231949978028

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Farzaneh Behelgardi, Maryam
Zahri, Saber
Mashayekhi, Farhad
Mansouri, Kamran
Asghari, S. Mohsen
SpringerLink (Online service)

Other Objects (12)

Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

Hochschulschrift

Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15

Hochschulschrift

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy

Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells

$Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis$

Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis

ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression

Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

Genetic variation determines VEGF-A plasma levels in cancer patients

Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

Hochschulschrift

Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15

Hochschulschrift

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy

Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells

$Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis$

Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis

ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression

Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

Genetic variation determines VEGF-A plasma levels in cancer patients

Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

Hochschulschrift

Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15

Hochschulschrift

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy

Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells

$Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis$

Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis

ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression

Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

Genetic variation determines VEGF-A plasma levels in cancer patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy

Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells

Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis

ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression

Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

Genetic variation determines VEGF-A plasma levels in cancer patients

Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy

Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells

Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis

ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression

Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

Genetic variation determines VEGF-A plasma levels in cancer patients

Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy

Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells

Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis

ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression

Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

Genetic variation determines VEGF-A plasma levels in cancer patients

Related objects

Reset password